• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tectonic Therapeutic, Inc. - Common Stock (NQ:TECX)

    27.91 -0.05 (-0.18%)
    Streaming Delayed Price Updated: 1:02 PM EDT, May 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Tectonic Therapeutic, Inc. - Common Stock

    News headline image
    Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Participate in March Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Participate in December Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Participate in September Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Joins Russell 3000® Index
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
    Late-breaking oral presentation to include full Phase 1b results for TX45 in the Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) cohort 
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Participate in March Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Announces $185 Million Private Placement
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
    American Heart Association (AHA) poster to be presented on November 16, 2024 
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic to Participate in September Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    News headline image
    Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
    From Tectonic Therapeutic
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.